Does Gilead Sciences have any subsidiaries?

Yes, Gilead Sciences has several subsidiaries. These subsidiaries include Kite Pharma, which focuses on developing innovative cell-based therapies for cancer treatment; Forty Seven Inc, which is dedicated to advancing novel immuno-oncology therapies; and Goldleaf Sciences, which specializes in the research and development of new drugs for inflammatory and fibrotic diseases. Additionally, Gilead Sciences also has subsidiaries such as Vedanta Biosciences, which focuses on developing therapies for the treatment of inflammatory bowel disease, and Phenex Pharmaceuticals AG, which focuses on discovering and developing therapeutics for liver and metabolic diseases. These subsidiaries allow Gilead Sciences to expand its reach in various therapeutic areas and further its commitment to advancing medical innovation.